STIMAXON

Serial Number 75145604
606

Registration Progress

Application Filed
Aug 6, 1996
Under Examination
Apr 29, 1997
Approved for Publication
Jan 4, 1997
Published for Opposition
Feb 4, 1997
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: STIMAXON
Previous Owner: Amgen Inc.
Classes: 005

Trademark Image

STIMAXON

Basic Information

Serial Number
75145604
Filing Date
August 6, 1996
Published for Opposition
February 4, 1997
Abandonment Date
April 30, 2000
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 30, 2000
Classes
005

Rights Holder

Amgen Inc.

03
Address
1840 DeHavilland Drive
Thousand Oaks, CA 91320

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
MARK I. FELDMAN

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

16 events
Date Code Type Description Documents
Jul 12, 2000 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 12, 1999 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 16, 1999 EXT5 S SOU EXTENSION 5 FILED Loading...
May 10, 1999 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 9, 1999 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 20, 1998 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 22, 1998 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 8, 1998 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 26, 1998 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 4, 1997 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 19, 1997 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 29, 1997 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 4, 1997 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 4, 1997 NPUB O NOTICE OF PUBLICATION Loading...
Dec 2, 1996 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 2, 1996 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
prescription pharmaceuticals for use in the treatment of neurological disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005